

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 8.52598315 |
| 2 | viral transcription (GO:0019083) | 8.52398281 |
| 3 | translational termination (GO:0006415) | 8.13982813 |
| 4 | ribosomal small subunit biogenesis (GO:0042274) | 7.90648028 |
| 5 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 7.22143649 |
| 6 | protein targeting to ER (GO:0045047) | 7.09307191 |
| 7 | cotranslational protein targeting to membrane (GO:0006613) | 7.08342717 |
| 8 | translational elongation (GO:0006414) | 6.92731233 |
| 9 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 6.74703569 |
| 10 | protein localization to endoplasmic reticulum (GO:0070972) | 6.71201561 |
| 11 | DNA deamination (GO:0045006) | 6.66839963 |
| 12 | viral life cycle (GO:0019058) | 6.37477423 |
| 13 | cellular protein complex disassembly (GO:0043624) | 6.31409055 |
| 14 | maturation of SSU-rRNA (GO:0030490) | 6.03158832 |
| 15 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 6.02831849 |
| 16 | ribosomal large subunit biogenesis (GO:0042273) | 5.97014311 |
| 17 | translational initiation (GO:0006413) | 5.85799641 |
| 18 | protein complex disassembly (GO:0043241) | 5.47983166 |
| 19 | macromolecular complex disassembly (GO:0032984) | 5.17780004 |
| 20 | translation (GO:0006412) | 4.76076418 |
| 21 | protein targeting to membrane (GO:0006612) | 4.73126540 |
| 22 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.26685288 |
| 23 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 4.24917342 |
| 24 | mRNA catabolic process (GO:0006402) | 4.05359532 |
| 25 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.95575335 |
| 26 | ATP synthesis coupled proton transport (GO:0015986) | 3.95575335 |
| 27 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.92451732 |
| 28 | heme biosynthetic process (GO:0006783) | 3.88465878 |
| 29 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.85901778 |
| 30 | RNA catabolic process (GO:0006401) | 3.81163847 |
| 31 | proteasome assembly (GO:0043248) | 3.81047508 |
| 32 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.80305746 |
| 33 | ncRNA 3-end processing (GO:0043628) | 3.79653682 |
| 34 | lipoxygenase pathway (GO:0019372) | 3.66379773 |
| 35 | low-density lipoprotein particle clearance (GO:0034383) | 3.54127890 |
| 36 | cellular component biogenesis (GO:0044085) | 3.53243750 |
| 37 | L-phenylalanine metabolic process (GO:0006558) | 3.52737644 |
| 38 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.52737644 |
| 39 | rRNA processing (GO:0006364) | 3.48661926 |
| 40 | protein maturation by protein folding (GO:0022417) | 3.48416468 |
| 41 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.47861721 |
| 42 | rRNA metabolic process (GO:0016072) | 3.42793321 |
| 43 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.42581456 |
| 44 | pseudouridine synthesis (GO:0001522) | 3.41775346 |
| 45 | establishment of protein localization to membrane (GO:0090150) | 3.32053032 |
| 46 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.30036681 |
| 47 | respiratory electron transport chain (GO:0022904) | 3.29340913 |
| 48 | electron transport chain (GO:0022900) | 3.19442683 |
| 49 | regulation of water loss via skin (GO:0033561) | 3.16854639 |
| 50 | protein targeting (GO:0006605) | 3.14978019 |
| 51 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.13855637 |
| 52 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.10588344 |
| 53 | DNA strand elongation (GO:0022616) | 3.10470656 |
| 54 | heme metabolic process (GO:0042168) | 3.10306591 |
| 55 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.05585697 |
| 56 | termination of RNA polymerase III transcription (GO:0006386) | 3.05585697 |
| 57 | glucose catabolic process (GO:0006007) | 3.00245402 |
| 58 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.97165679 |
| 59 | iron-sulfur cluster assembly (GO:0016226) | 2.95665936 |
| 60 | metallo-sulfur cluster assembly (GO:0031163) | 2.95665936 |
| 61 | primary alcohol catabolic process (GO:0034310) | 2.95189121 |
| 62 | establishment of protein localization to organelle (GO:0072594) | 2.93537451 |
| 63 | amyloid precursor protein catabolic process (GO:0042987) | 2.92148008 |
| 64 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.91198105 |
| 65 | antibacterial humoral response (GO:0019731) | 2.90124960 |
| 66 | telomere maintenance via recombination (GO:0000722) | 2.83350045 |
| 67 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.82978039 |
| 68 | respiratory chain complex IV assembly (GO:0008535) | 2.82723221 |
| 69 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.82654153 |
| 70 | neutrophil activation involved in immune response (GO:0002283) | 2.82618452 |
| 71 | antimicrobial humoral response (GO:0019730) | 2.80658297 |
| 72 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.79070634 |
| 73 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.78496915 |
| 74 | establishment of skin barrier (GO:0061436) | 2.78033284 |
| 75 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.77400247 |
| 76 | spliceosomal snRNP assembly (GO:0000387) | 2.76399485 |
| 77 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.75945852 |
| 78 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.75599071 |
| 79 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.75515972 |
| 80 | deoxyribonucleotide catabolic process (GO:0009264) | 2.74859238 |
| 81 | pentose metabolic process (GO:0019321) | 2.74518904 |
| 82 | triglyceride catabolic process (GO:0019433) | 2.72927538 |
| 83 | NADPH regeneration (GO:0006740) | 2.71946158 |
| 84 | mitotic nuclear envelope reassembly (GO:0007084) | 2.70355234 |
| 85 | nuclear envelope reassembly (GO:0031468) | 2.70355234 |
| 86 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.69954441 |
| 87 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.69399299 |
| 88 | DNA replication checkpoint (GO:0000076) | 2.69214451 |
| 89 | hydrogen peroxide catabolic process (GO:0042744) | 2.66955100 |
| 90 | desmosome organization (GO:0002934) | 2.65984390 |
| 91 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.64695529 |
| 92 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.61946182 |
| 93 | pentose-phosphate shunt (GO:0006098) | 2.61036707 |
| 94 | ethanol metabolic process (GO:0006067) | 2.61023070 |
| 95 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.60955272 |
| 96 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.60634677 |
| 97 | negative regulation of ligase activity (GO:0051352) | 2.60634677 |
| 98 | L-phenylalanine catabolic process (GO:0006559) | 2.60056053 |
| 99 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.60056053 |
| 100 | regulation of mitochondrial translation (GO:0070129) | 2.58927742 |
| 101 | cellular response to arsenic-containing substance (GO:0071243) | 2.57915265 |
| 102 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.57504244 |
| 103 | peptidyl-histidine modification (GO:0018202) | 2.57124543 |
| 104 | protein targeting to mitochondrion (GO:0006626) | 2.56178268 |
| 105 | Golgi transport vesicle coating (GO:0048200) | 2.56072671 |
| 106 | COPI coating of Golgi vesicle (GO:0048205) | 2.56072671 |
| 107 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.55853417 |
| 108 | viral protein processing (GO:0019082) | 2.55770379 |
| 109 | NADH metabolic process (GO:0006734) | 2.55621112 |
| 110 | formation of translation preinitiation complex (GO:0001731) | 2.55619517 |
| 111 | virion assembly (GO:0019068) | 2.55411871 |
| 112 | protein localization to membrane (GO:0072657) | 2.54477921 |
| 113 | cellular response to zinc ion (GO:0071294) | 2.54074164 |
| 114 | protein complex biogenesis (GO:0070271) | 2.53410516 |
| 115 | glutathione metabolic process (GO:0006749) | 2.53340761 |
| 116 | GTP biosynthetic process (GO:0006183) | 2.53120744 |
| 117 | multicellular organismal water homeostasis (GO:0050891) | 2.51671919 |
| 118 | negative regulation of granulocyte differentiation (GO:0030853) | 2.50742373 |
| 119 | nitrogen cycle metabolic process (GO:0071941) | 2.50496229 |
| 120 | glutathione biosynthetic process (GO:0006750) | 2.50231420 |
| 121 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.49651079 |
| 122 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.49651079 |
| 123 | GDP-mannose metabolic process (GO:0019673) | 2.49338883 |
| 124 | spliceosomal complex assembly (GO:0000245) | 2.48932487 |
| 125 | glutathione derivative biosynthetic process (GO:1901687) | 2.48747444 |
| 126 | glutathione derivative metabolic process (GO:1901685) | 2.48747444 |
| 127 | deoxyribose phosphate catabolic process (GO:0046386) | 2.48656333 |
| 128 | telomere maintenance via telomere lengthening (GO:0010833) | 2.48082936 |
| 129 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.48065394 |
| 130 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.47983178 |
| 131 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.47808465 |
| 132 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.47216088 |
| 133 | regulation of metalloenzyme activity (GO:0048552) | 2.46962893 |
| 134 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.46875460 |
| 135 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.46875460 |
| 136 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.46875460 |
| 137 | establishment of protein localization to mitochondrion (GO:0072655) | 2.46566663 |
| 138 | mitotic recombination (GO:0006312) | 2.46227895 |
| 139 | tetrapyrrole biosynthetic process (GO:0033014) | 2.45839027 |
| 140 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.45406079 |
| 141 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.45406079 |
| 142 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.45094861 |
| 143 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.44654061 |
| 144 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.44654061 |
| 145 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.44219018 |
| 146 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.44054857 |
| 147 | primary alcohol metabolic process (GO:0034308) | 2.43113234 |
| 148 | keratan sulfate catabolic process (GO:0042340) | 2.42821284 |
| 149 | urea cycle (GO:0000050) | 2.42146205 |
| 150 | peroxisome fission (GO:0016559) | 2.42092452 |
| 151 | autophagic vacuole fusion (GO:0000046) | 2.37650433 |
| 152 | norepinephrine metabolic process (GO:0042415) | 2.37081164 |
| 153 | neutral lipid catabolic process (GO:0046461) | 2.36400747 |
| 154 | acylglycerol catabolic process (GO:0046464) | 2.36400747 |
| 155 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.34908532 |
| 156 | extracellular fibril organization (GO:0043206) | 2.32364451 |
| 157 | daunorubicin metabolic process (GO:0044597) | 2.31818024 |
| 158 | polyketide metabolic process (GO:0030638) | 2.31818024 |
| 159 | doxorubicin metabolic process (GO:0044598) | 2.31818024 |
| 160 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.31017331 |
| 161 | barbed-end actin filament capping (GO:0051016) | 2.30440258 |
| 162 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.29240718 |
| 163 | negative regulation of stress fiber assembly (GO:0051497) | 2.27817445 |
| 164 | nitric oxide biosynthetic process (GO:0006809) | 2.27744960 |
| 165 | retinol metabolic process (GO:0042572) | 2.27152924 |
| 166 | negative regulation of adherens junction organization (GO:1903392) | 2.25924615 |
| 167 | negative regulation of focal adhesion assembly (GO:0051895) | 2.25924615 |
| 168 | negative regulation of cell junction assembly (GO:1901889) | 2.25924615 |
| 169 | NADP metabolic process (GO:0006739) | 2.24152487 |
| 170 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.24017916 |
| 171 | very long-chain fatty acid metabolic process (GO:0000038) | 2.23577667 |
| 172 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.23124496 |
| 173 | amyloid precursor protein metabolic process (GO:0042982) | 2.23001609 |
| 174 | fibril organization (GO:0097435) | 2.22452139 |
| 175 | cellular response to antibiotic (GO:0071236) | 2.22266851 |
| 176 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.21792262 |
| 177 | cyclooxygenase pathway (GO:0019371) | 2.20632825 |
| 178 | type B pancreatic cell proliferation (GO:0044342) | 2.20298872 |
| 179 | intestinal epithelial cell development (GO:0060576) | 2.19720906 |
| 180 | regulation of cholesterol storage (GO:0010885) | 2.19646059 |
| 181 | biotin metabolic process (GO:0006768) | 2.18866057 |
| 182 | immunoglobulin mediated immune response (GO:0016064) | 2.18106341 |
| 183 | mesonephros development (GO:0001823) | 2.16707101 |
| 184 | urea metabolic process (GO:0019627) | 2.16324810 |
| 185 | ethanol oxidation (GO:0006069) | 2.15448210 |
| 186 | endothelial cell chemotaxis (GO:0035767) | 2.15315497 |
| 187 | water homeostasis (GO:0030104) | 2.15091362 |
| 188 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.14588335 |
| 189 | hepatocyte apoptotic process (GO:0097284) | 2.14071481 |
| 190 | xenobiotic catabolic process (GO:0042178) | 2.13574191 |
| 191 | hydrogen peroxide metabolic process (GO:0042743) | 2.13572036 |
| 192 | positive regulation of protein homodimerization activity (GO:0090073) | 2.13021145 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.46290251 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.03435561 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.92566807 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.69298034 |
| 5 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 3.15713995 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.95114659 |
| 7 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.92256801 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.88330950 |
| 9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.87442413 |
| 10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.82380856 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.79871577 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.75297301 |
| 13 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.75128884 |
| 14 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.70088632 |
| 15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.64134098 |
| 16 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.61303243 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.55223042 |
| 18 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.48676563 |
| 19 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.38369103 |
| 20 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.33885006 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.29142463 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.27232648 |
| 23 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26954675 |
| 24 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.24503145 |
| 25 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.20331165 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.13825609 |
| 27 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.10997649 |
| 28 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.07135166 |
| 29 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.04892497 |
| 30 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.03599402 |
| 31 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.02624406 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01764555 |
| 33 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.01627548 |
| 34 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.01022885 |
| 35 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.95543008 |
| 36 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.95496307 |
| 37 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.93933770 |
| 38 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.93712109 |
| 39 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.92952601 |
| 40 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.90474458 |
| 41 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.88331426 |
| 42 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.87622409 |
| 43 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.80387874 |
| 44 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.73890859 |
| 45 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.68778154 |
| 46 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.67932468 |
| 47 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.66416464 |
| 48 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.65826250 |
| 49 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.64884077 |
| 50 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.63730807 |
| 51 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.62086970 |
| 52 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.61480108 |
| 53 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.61007367 |
| 54 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.59146147 |
| 55 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.57300907 |
| 56 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56132222 |
| 57 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.53518940 |
| 58 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.52979979 |
| 59 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52617928 |
| 60 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.51007636 |
| 61 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.50921624 |
| 62 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.49884572 |
| 63 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.49793682 |
| 64 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.49773451 |
| 65 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.47434653 |
| 66 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46301350 |
| 67 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.45332428 |
| 68 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.44221043 |
| 69 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.42941624 |
| 70 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.37188744 |
| 71 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.37095550 |
| 72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.35499941 |
| 73 | P68_20966046_ChIP-Seq_HELA_Human | 1.34573121 |
| 74 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.34306392 |
| 75 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.33843874 |
| 76 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.30073852 |
| 77 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.28376241 |
| 78 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27409017 |
| 79 | MYC_22102868_ChIP-Seq_BL_Human | 1.26188566 |
| 80 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.26021223 |
| 81 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.25746621 |
| 82 | ATF3_27146783_Chip-Seq_COLON_Human | 1.25501202 |
| 83 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.25366519 |
| 84 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.24692774 |
| 85 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.23545923 |
| 86 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.22321055 |
| 87 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.21849593 |
| 88 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.20542706 |
| 89 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.20245713 |
| 90 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.19759582 |
| 91 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.19022642 |
| 92 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.18608067 |
| 93 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.18291060 |
| 94 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.17245375 |
| 95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16336075 |
| 96 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16167654 |
| 97 | * MAF_26560356_Chip-Seq_TH2_Human | 1.15460925 |
| 98 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.15405006 |
| 99 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.15047761 |
| 100 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.14683692 |
| 101 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.14429329 |
| 102 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.13954570 |
| 103 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.13711755 |
| 104 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.13518227 |
| 105 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.13105066 |
| 106 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.13029318 |
| 107 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.12952436 |
| 108 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12935677 |
| 109 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.12867096 |
| 110 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12315496 |
| 111 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.11289948 |
| 112 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.11276828 |
| 113 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.10857819 |
| 114 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10689546 |
| 115 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.10045165 |
| 116 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09386072 |
| 117 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.08777671 |
| 118 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.08764745 |
| 119 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.08657709 |
| 120 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06034349 |
| 121 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.05965905 |
| 122 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05859114 |
| 123 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.05474526 |
| 124 | MAF_26560356_Chip-Seq_TH1_Human | 1.05461041 |
| 125 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.04967293 |
| 126 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.04903075 |
| 127 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.04722565 |
| 128 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04316279 |
| 129 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04270572 |
| 130 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.03941897 |
| 131 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02885091 |
| 132 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.02357410 |
| 133 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01904816 |
| 134 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.01752581 |
| 135 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.01585322 |
| 136 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.01387637 |
| 137 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.01161302 |
| 138 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.00708975 |
| 139 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.00360393 |
| 140 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00171803 |
| 141 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.00064723 |
| 142 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.00020990 |
| 143 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.00000509 |
| 144 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.99605621 |
| 145 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99085512 |
| 146 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98481389 |
| 147 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.98002646 |
| 148 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.97795677 |
| 149 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.97752961 |
| 150 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.97649152 |
| 151 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97556971 |
| 152 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.97214026 |
| 153 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.96831350 |
| 154 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.96687495 |
| 155 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.95496580 |
| 156 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.95195456 |
| 157 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94557921 |
| 158 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.94405073 |
| 159 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93651176 |
| 160 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.93473157 |
| 161 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.93316834 |
| 162 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.93290270 |
| 163 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.92529223 |
| 164 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.90905349 |
| 165 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.90352309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 4.30842010 |
| 2 | MP0003693_abnormal_embryo_hatching | 3.25291317 |
| 3 | MP0005670_abnormal_white_adipose | 3.24182344 |
| 4 | MP0000490_abnormal_crypts_of | 2.52947575 |
| 5 | MP0005666_abnormal_adipose_tissue | 2.51179219 |
| 6 | MP0004957_abnormal_blastocyst_morpholog | 2.48455568 |
| 7 | MP0009333_abnormal_splenocyte_physiolog | 2.37868757 |
| 8 | MP0004185_abnormal_adipocyte_glucose | 2.23990111 |
| 9 | MP0003186_abnormal_redox_activity | 2.23759141 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 2.20800088 |
| 11 | MP0001873_stomach_inflammation | 2.13178432 |
| 12 | MP0009780_abnormal_chondrocyte_physiolo | 2.05792906 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.03092936 |
| 14 | MP0000685_abnormal_immune_system | 2.02569310 |
| 15 | MP0009785_altered_susceptibility_to | 2.02555234 |
| 16 | MP0010155_abnormal_intestine_physiology | 2.01316975 |
| 17 | MP0002396_abnormal_hematopoietic_system | 2.00058988 |
| 18 | MP0002132_abnormal_respiratory_system | 1.97517215 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 1.95423321 |
| 20 | MP0004147_increased_porphyrin_level | 1.94578528 |
| 21 | MP0004381_abnormal_hair_follicle | 1.93349265 |
| 22 | MP0003656_abnormal_erythrocyte_physiolo | 1.92511562 |
| 23 | MP0005025_abnormal_response_to | 1.90483813 |
| 24 | MP0005375_adipose_tissue_phenotype | 1.87317044 |
| 25 | MP0003436_decreased_susceptibility_to | 1.83851444 |
| 26 | MP0003763_abnormal_thymus_physiology | 1.79936970 |
| 27 | MP0005671_abnormal_response_to | 1.76464779 |
| 28 | MP0008438_abnormal_cutaneous_collagen | 1.76202332 |
| 29 | MP0001835_abnormal_antigen_presentation | 1.75944610 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 1.74724495 |
| 31 | MP0003866_abnormal_defecation | 1.71252559 |
| 32 | MP0002139_abnormal_hepatobiliary_system | 1.70960139 |
| 33 | MP0003724_increased_susceptibility_to | 1.63594953 |
| 34 | MP0005000_abnormal_immune_tolerance | 1.63094966 |
| 35 | MP0003111_abnormal_nucleus_morphology | 1.62923771 |
| 36 | MP0008932_abnormal_embryonic_tissue | 1.61138699 |
| 37 | MP0002971_abnormal_brown_adipose | 1.60037414 |
| 38 | MP0003077_abnormal_cell_cycle | 1.59938720 |
| 39 | MP0003172_abnormal_lysosome_physiology | 1.58431025 |
| 40 | MP0000858_altered_metastatic_potential | 1.56827206 |
| 41 | MP0005083_abnormal_biliary_tract | 1.55939965 |
| 42 | MP0001663_abnormal_digestive_system | 1.55811945 |
| 43 | MP0002420_abnormal_adaptive_immunity | 1.55605403 |
| 44 | MP0002398_abnormal_bone_marrow | 1.54658300 |
| 45 | MP0001819_abnormal_immune_cell | 1.53936497 |
| 46 | MP0005275_abnormal_skin_tensile | 1.51357607 |
| 47 | MP0002723_abnormal_immune_serum | 1.50434267 |
| 48 | MP0002405_respiratory_system_inflammati | 1.50197202 |
| 49 | MP0002452_abnormal_antigen_presenting | 1.49082957 |
| 50 | MP0001800_abnormal_humoral_immune | 1.47705132 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.47465316 |
| 52 | MP0005174_abnormal_tail_pigmentation | 1.47157408 |
| 53 | MP0002722_abnormal_immune_system | 1.44819567 |
| 54 | MP0005381_digestive/alimentary_phenotyp | 1.43357875 |
| 55 | MP0009840_abnormal_foam_cell | 1.42340842 |
| 56 | MP0000716_abnormal_immune_system | 1.41785780 |
| 57 | MP0004264_abnormal_extraembryonic_tissu | 1.40190278 |
| 58 | MP0002429_abnormal_blood_cell | 1.39103742 |
| 59 | MP0000689_abnormal_spleen_morphology | 1.38777044 |
| 60 | MP0002166_altered_tumor_susceptibility | 1.37431736 |
| 61 | MP0001790_abnormal_immune_system | 1.36567224 |
| 62 | MP0005387_immune_system_phenotype | 1.36567224 |
| 63 | MP0005075_abnormal_melanosome_morpholog | 1.36059650 |
| 64 | MP0005501_abnormal_skin_physiology | 1.35871202 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 1.34938149 |
| 66 | MP0001545_abnormal_hematopoietic_system | 1.34938149 |
| 67 | MP0010329_abnormal_lipoprotein_level | 1.34607464 |
| 68 | MP0010094_abnormal_chromosome_stability | 1.34218158 |
| 69 | MP0002419_abnormal_innate_immunity | 1.33190198 |
| 70 | MP0002909_abnormal_adrenal_gland | 1.31954928 |
| 71 | MP0000477_abnormal_intestine_morphology | 1.27557050 |
| 72 | MP0005365_abnormal_bile_salt | 1.25849218 |
| 73 | MP0008875_abnormal_xenobiotic_pharmacok | 1.24725601 |
| 74 | MP0006036_abnormal_mitochondrial_physio | 1.24500698 |
| 75 | MP0001542_abnormal_bone_strength | 1.23959049 |
| 76 | MP0010030_abnormal_orbit_morphology | 1.23953557 |
| 77 | MP0004510_myositis | 1.23628408 |
| 78 | MP0001348_abnormal_lacrimal_gland | 1.22411163 |
| 79 | MP0003303_peritoneal_inflammation | 1.20779283 |
| 80 | MP0005503_abnormal_tendon_morphology | 1.19295169 |
| 81 | MP0000462_abnormal_digestive_system | 1.19230545 |
| 82 | MP0003453_abnormal_keratinocyte_physiol | 1.18947045 |
| 83 | MP0001845_abnormal_inflammatory_respons | 1.18924734 |
| 84 | MP0000703_abnormal_thymus_morphology | 1.17048014 |
| 85 | MP0002019_abnormal_tumor_incidence | 1.14950483 |
| 86 | MP0003638_abnormal_response/metabolism_ | 1.14933901 |
| 87 | MP0004947_skin_inflammation | 1.13387628 |
| 88 | MP0005451_abnormal_body_composition | 1.12004361 |
| 89 | MP0005636_abnormal_mineral_homeostasis | 1.11479309 |
| 90 | MP0003566_abnormal_cell_adhesion | 1.11402888 |
| 91 | MP0004019_abnormal_vitamin_homeostasis | 1.11307289 |
| 92 | MP0002796_impaired_skin_barrier | 1.10973832 |
| 93 | MP0001764_abnormal_homeostasis | 1.10690565 |
| 94 | MP0003075_altered_response_to | 1.10528067 |
| 95 | MP0003315_abnormal_perineum_morphology | 1.10102042 |
| 96 | MP0002118_abnormal_lipid_homeostasis | 1.09056219 |
| 97 | MP0008260_abnormal_autophagy | 1.08876590 |
| 98 | MP0005464_abnormal_platelet_physiology | 1.08784096 |
| 99 | MP0009643_abnormal_urine_homeostasis | 1.08774877 |
| 100 | MP0006082_CNS_inflammation | 1.07390836 |
| 101 | MP0000613_abnormal_salivary_gland | 1.06218481 |
| 102 | MP0009384_cardiac_valve_regurgitation | 1.05729476 |
| 103 | MP0008469_abnormal_protein_level | 1.03346690 |
| 104 | MP0001853_heart_inflammation | 1.03066775 |
| 105 | MP0003279_aneurysm | 1.02275460 |
| 106 | MP0002970_abnormal_white_adipose | 1.01980053 |
| 107 | MP0002933_joint_inflammation | 1.01908996 |
| 108 | MP0000003_abnormal_adipose_tissue | 1.01815233 |
| 109 | MP0000313_abnormal_cell_death | 1.01497046 |
| 110 | MP0003191_abnormal_cellular_cholesterol | 1.01397814 |
| 111 | MP0005319_abnormal_enzyme/_coenzyme | 1.01330302 |
| 112 | MP0008007_abnormal_cellular_replicative | 1.01320865 |
| 113 | MP0002006_tumorigenesis | 1.01008219 |
| 114 | MP0010352_gastrointestinal_tract_polyps | 1.00963084 |
| 115 | MP0010771_integument_phenotype | 1.00333236 |
| 116 | MP0003136_yellow_coat_color | 0.98678695 |
| 117 | MP0005334_abnormal_fat_pad | 0.97699190 |
| 118 | MP0005535_abnormal_body_temperature | 0.95376465 |
| 119 | MP0005377_hearing/vestibular/ear_phenot | 0.95193407 |
| 120 | MP0003878_abnormal_ear_physiology | 0.95193407 |
| 121 | MP0009115_abnormal_fat_cell | 0.93642303 |
| 122 | MP0003786_premature_aging | 0.93348946 |
| 123 | MP0001881_abnormal_mammary_gland | 0.93341006 |
| 124 | MP0008004_abnormal_stomach_pH | 0.92164992 |
| 125 | MP0005058_abnormal_lysosome_morphology | 0.91627614 |
| 126 | MP0005165_increased_susceptibility_to | 0.91576624 |
| 127 | MP0004130_abnormal_muscle_cell | 0.91053045 |
| 128 | MP0005310_abnormal_salivary_gland | 0.91045259 |
| 129 | MP0008058_abnormal_DNA_repair | 0.90445771 |
| 130 | MP0000609_abnormal_liver_physiology | 0.90044885 |
| 131 | MP0003879_abnormal_hair_cell | 0.89980998 |
| 132 | MP0003011_delayed_dark_adaptation | 0.89356219 |
| 133 | MP0003300_gastrointestinal_ulcer | 0.87870007 |
| 134 | MP0000681_abnormal_thyroid_gland | 0.87523231 |
| 135 | MP0002098_abnormal_vibrissa_morphology | 0.87031964 |
| 136 | MP0005408_hypopigmentation | 0.86932763 |
| 137 | MP0002060_abnormal_skin_morphology | 0.86580840 |
| 138 | MP0001533_abnormal_skeleton_physiology | 0.85940466 |
| 139 | MP0001756_abnormal_urination | 0.84699295 |
| 140 | MP0000678_abnormal_parathyroid_gland | 0.84370720 |
| 141 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.83904012 |
| 142 | MP0002277_abnormal_respiratory_mucosa | 0.82629097 |
| 143 | MP0002998_abnormal_bone_remodeling | 0.82202707 |
| 144 | MP0001661_extended_life_span | 0.81835260 |
| 145 | MP0001664_abnormal_digestion | 0.81177043 |
| 146 | MP0001216_abnormal_epidermal_layer | 0.80656128 |
| 147 | MP0005360_urolithiasis | 0.80646862 |
| 148 | MP0000013_abnormal_adipose_tissue | 0.80460057 |
| 149 | MP0000538_abnormal_urinary_bladder | 0.79244909 |
| 150 | MP0005390_skeleton_phenotype | 0.78560091 |
| 151 | MP0000343_altered_response_to | 0.77867948 |
| 152 | MP0001849_ear_inflammation | 0.77729266 |
| 153 | MP0005084_abnormal_gallbladder_morpholo | 0.76987959 |
| 154 | MP0003718_maternal_effect | 0.74452365 |
| 155 | MP0002138_abnormal_hepatobiliary_system | 0.74004436 |
| 156 | MP0000470_abnormal_stomach_morphology | 0.73824905 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 7.33265663 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 6.63342545 |
| 3 | Reticulocytopenia (HP:0001896) | 5.87068882 |
| 4 | Macrocytic anemia (HP:0001972) | 4.93656250 |
| 5 | Pallor (HP:0000980) | 4.49320576 |
| 6 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 4.30322326 |
| 7 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.97985862 |
| 8 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.92018467 |
| 9 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.92018467 |
| 10 | Hepatocellular necrosis (HP:0001404) | 3.74174854 |
| 11 | Mitochondrial inheritance (HP:0001427) | 3.62333460 |
| 12 | Increased hepatocellular lipid droplets (HP:0006565) | 3.49917017 |
| 13 | J-shaped sella turcica (HP:0002680) | 3.48375559 |
| 14 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.47047332 |
| 15 | Abnormal hemoglobin (HP:0011902) | 3.46878979 |
| 16 | Hepatic necrosis (HP:0002605) | 3.37728682 |
| 17 | Increased intramyocellular lipid droplets (HP:0012240) | 3.35849887 |
| 18 | Dysostosis multiplex (HP:0000943) | 3.33526171 |
| 19 | Lipid accumulation in hepatocytes (HP:0006561) | 3.25877068 |
| 20 | Abnormality of the nasal mucosa (HP:0000433) | 3.18915784 |
| 21 | Renal Fanconi syndrome (HP:0001994) | 3.16204976 |
| 22 | Abnormality of glycolipid metabolism (HP:0010969) | 3.14451440 |
| 23 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.14451440 |
| 24 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.14451440 |
| 25 | Nasal polyposis (HP:0100582) | 3.14200282 |
| 26 | Thrombocytosis (HP:0001894) | 3.09928225 |
| 27 | Acute necrotizing encephalopathy (HP:0006965) | 3.08610595 |
| 28 | Exertional dyspnea (HP:0002875) | 3.08388352 |
| 29 | Petechiae (HP:0000967) | 3.05185560 |
| 30 | Increased muscle lipid content (HP:0009058) | 3.04804419 |
| 31 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.03387013 |
| 32 | Distal lower limb muscle weakness (HP:0009053) | 2.99895554 |
| 33 | Pustule (HP:0200039) | 2.99260646 |
| 34 | Increased CSF lactate (HP:0002490) | 2.95236486 |
| 35 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.92945651 |
| 36 | Axonal loss (HP:0003447) | 2.91780239 |
| 37 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.89809217 |
| 38 | Vertebral compression fractures (HP:0002953) | 2.85089389 |
| 39 | Cervical subluxation (HP:0003308) | 2.79742355 |
| 40 | Prolonged neonatal jaundice (HP:0006579) | 2.77873332 |
| 41 | 3-Methylglutaconic aciduria (HP:0003535) | 2.74486089 |
| 42 | Trismus (HP:0000211) | 2.74440935 |
| 43 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.71636831 |
| 44 | Hypertriglyceridemia (HP:0002155) | 2.71350855 |
| 45 | Microvesicular hepatic steatosis (HP:0001414) | 2.71004282 |
| 46 | Acute encephalopathy (HP:0006846) | 2.70040837 |
| 47 | Growth hormone excess (HP:0000845) | 2.65796300 |
| 48 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.64918027 |
| 49 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.64918027 |
| 50 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.64918027 |
| 51 | Increased serum lactate (HP:0002151) | 2.63909489 |
| 52 | Microretrognathia (HP:0000308) | 2.62251748 |
| 53 | Mucopolysacchariduria (HP:0008155) | 2.59450032 |
| 54 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.59450032 |
| 55 | Chronic sinusitis (HP:0011109) | 2.58675161 |
| 56 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.56299239 |
| 57 | Abnormality of the Achilles tendon (HP:0005109) | 2.56099657 |
| 58 | Testicular atrophy (HP:0000029) | 2.54839125 |
| 59 | Prolonged bleeding time (HP:0003010) | 2.53860698 |
| 60 | Acanthosis nigricans (HP:0000956) | 2.51136141 |
| 61 | Respiratory failure (HP:0002878) | 2.47900185 |
| 62 | Systemic lupus erythematosus (HP:0002725) | 2.45358129 |
| 63 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.44300501 |
| 64 | Type I transferrin isoform profile (HP:0003642) | 2.43192722 |
| 65 | Achilles tendon contracture (HP:0001771) | 2.39475861 |
| 66 | Chronic otitis media (HP:0000389) | 2.39261806 |
| 67 | Increased cerebral lipofuscin (HP:0011813) | 2.37185464 |
| 68 | Abnormality of reticulocytes (HP:0004312) | 2.35373167 |
| 69 | Oral leukoplakia (HP:0002745) | 2.33297304 |
| 70 | Progressive neurologic deterioration (HP:0002344) | 2.32615484 |
| 71 | Hyperparathyroidism (HP:0000843) | 2.31779308 |
| 72 | Cerebral hypomyelination (HP:0006808) | 2.30671909 |
| 73 | Lactic acidosis (HP:0003128) | 2.29971261 |
| 74 | Aplastic anemia (HP:0001915) | 2.27719362 |
| 75 | Increased serum ferritin (HP:0003281) | 2.26212169 |
| 76 | Progressive macrocephaly (HP:0004481) | 2.25516208 |
| 77 | Menorrhagia (HP:0000132) | 2.25130081 |
| 78 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.25113852 |
| 79 | Basal ganglia calcification (HP:0002135) | 2.22004627 |
| 80 | Hyperphosphaturia (HP:0003109) | 2.21697425 |
| 81 | IgM deficiency (HP:0002850) | 2.19167331 |
| 82 | Rough bone trabeculation (HP:0100670) | 2.18280229 |
| 83 | Poikiloderma (HP:0001029) | 2.17777258 |
| 84 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.16848510 |
| 85 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.16848510 |
| 86 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.16227217 |
| 87 | Exercise intolerance (HP:0003546) | 2.15608504 |
| 88 | Respiratory difficulties (HP:0002880) | 2.13126168 |
| 89 | Nuclear cataract (HP:0100018) | 2.12861800 |
| 90 | Abnormal protein glycosylation (HP:0012346) | 2.10662222 |
| 91 | Abnormal glycosylation (HP:0012345) | 2.10662222 |
| 92 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.10662222 |
| 93 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.10662222 |
| 94 | Testicular neoplasm (HP:0010788) | 2.10556160 |
| 95 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.10356419 |
| 96 | Vacuolated lymphocytes (HP:0001922) | 2.10267103 |
| 97 | Ileus (HP:0002595) | 2.10232051 |
| 98 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.07691477 |
| 99 | Progressive muscle weakness (HP:0003323) | 2.07134762 |
| 100 | Gingival bleeding (HP:0000225) | 2.05143811 |
| 101 | Amniotic constriction ring (HP:0009775) | 2.05075768 |
| 102 | Abnormality of placental membranes (HP:0011409) | 2.05075768 |
| 103 | Recurrent abscess formation (HP:0002722) | 2.04215903 |
| 104 | Abnormal ciliary motility (HP:0012262) | 2.03993704 |
| 105 | Breast hypoplasia (HP:0003187) | 2.02759957 |
| 106 | Abnormality of renal resorption (HP:0011038) | 2.02326016 |
| 107 | Abnormality of macrophages (HP:0004311) | 2.00110300 |
| 108 | Poor head control (HP:0002421) | 1.99520900 |
| 109 | Pancytopenia (HP:0001876) | 1.99224684 |
| 110 | Long toe (HP:0010511) | 1.97672454 |
| 111 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.96937297 |
| 112 | Flat capital femoral epiphysis (HP:0003370) | 1.96560651 |
| 113 | Concave nail (HP:0001598) | 1.96478665 |
| 114 | Reduced antithrombin III activity (HP:0001976) | 1.94675702 |
| 115 | Microcytic anemia (HP:0001935) | 1.94294841 |
| 116 | Xanthomatosis (HP:0000991) | 1.93719171 |
| 117 | Joint stiffness (HP:0001387) | 1.93105273 |
| 118 | Dicarboxylic aciduria (HP:0003215) | 1.93053922 |
| 119 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.93053922 |
| 120 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.92818704 |
| 121 | Absent/shortened dynein arms (HP:0200106) | 1.92818704 |
| 122 | Erythema (HP:0010783) | 1.92623471 |
| 123 | Epistaxis (HP:0000421) | 1.92378654 |
| 124 | Paralysis (HP:0003470) | 1.92285622 |
| 125 | Cerebral edema (HP:0002181) | 1.92185983 |
| 126 | Bulbar palsy (HP:0001283) | 1.92048354 |
| 127 | Stridor (HP:0010307) | 1.90317489 |
| 128 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.87203440 |
| 129 | Cheilitis (HP:0100825) | 1.86007106 |
| 130 | Bone cyst (HP:0012062) | 1.85486260 |
| 131 | Asplenia (HP:0001746) | 1.85451511 |
| 132 | Purpura (HP:0000979) | 1.85054075 |
| 133 | Abnormality of T cell physiology (HP:0011840) | 1.83660950 |
| 134 | Cardiomegaly (HP:0001640) | 1.83411085 |
| 135 | Parakeratosis (HP:0001036) | 1.81599173 |
| 136 | Partial duplication of thumb phalanx (HP:0009944) | 1.80823713 |
| 137 | Large eyes (HP:0001090) | 1.80652390 |
| 138 | Hypercortisolism (HP:0001578) | 1.79762275 |
| 139 | Abnormal urine phosphate concentration (HP:0012599) | 1.78781853 |
| 140 | Eczematoid dermatitis (HP:0000976) | 1.78090762 |
| 141 | Absent thumb (HP:0009777) | 1.77465077 |
| 142 | Hypoplasia of the radius (HP:0002984) | 1.76970956 |
| 143 | Glycosuria (HP:0003076) | 1.76687793 |
| 144 | Abnormality of urine glucose concentration (HP:0011016) | 1.76687793 |
| 145 | Sparse lateral eyebrow (HP:0005338) | 1.76438950 |
| 146 | Rhabdomyolysis (HP:0003201) | 1.76356303 |
| 147 | Abnormality of magnesium homeostasis (HP:0004921) | 1.75872602 |
| 148 | Glomerulonephritis (HP:0000099) | 1.75178913 |
| 149 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.74900176 |
| 150 | Oligomenorrhea (HP:0000876) | 1.74802016 |
| 151 | Severe combined immunodeficiency (HP:0004430) | 1.74717320 |
| 152 | Stenosis of the external auditory canal (HP:0000402) | 1.74586690 |
| 153 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.74146432 |
| 154 | Partial duplication of the phalanx of hand (HP:0009999) | 1.73903404 |
| 155 | Sparse eyelashes (HP:0000653) | 1.73796250 |
| 156 | Vascular calcification (HP:0004934) | 1.73595026 |
| 157 | Septate vagina (HP:0001153) | 1.73255043 |
| 158 | Seborrheic dermatitis (HP:0001051) | 1.72998626 |
| 159 | Granulocytopenia (HP:0001913) | 1.72603365 |
| 160 | Obstructive lung disease (HP:0006536) | 1.71774913 |
| 161 | Chronic obstructive pulmonary disease (HP:0006510) | 1.71774913 |
| 162 | Cerebral palsy (HP:0100021) | 1.71691928 |
| 163 | Elbow flexion contracture (HP:0002987) | 1.71582655 |
| 164 | Hyperlipoproteinemia (HP:0010980) | 1.70452937 |
| 165 | Cutaneous photosensitivity (HP:0000992) | 1.69777060 |
| 166 | Hyperammonemia (HP:0001987) | 1.68561098 |
| 167 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.68464986 |
| 168 | Osteolytic defects of the hand bones (HP:0009699) | 1.68464986 |
| 169 | 11 pairs of ribs (HP:0000878) | 1.67206438 |
| 170 | Hemorrhage of the eye (HP:0011885) | 1.66937382 |
| 171 | Premature rupture of membranes (HP:0001788) | 1.66850258 |
| 172 | Broad face (HP:0000283) | 1.66239957 |
| 173 | Hepatosplenomegaly (HP:0001433) | 1.66161442 |
| 174 | Depressed nasal ridge (HP:0000457) | 1.65936264 |
| 175 | Hyperthyroidism (HP:0000836) | 1.65869911 |
| 176 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.65729990 |
| 177 | Urticaria (HP:0001025) | 1.63365493 |
| 178 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.62470677 |
| 179 | Panhypogammaglobulinemia (HP:0003139) | 1.62317797 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 5.04673783 |
| 2 | NME2 | 4.95937364 |
| 3 | TRIB3 | 3.90846173 |
| 4 | EIF2AK1 | 3.24939019 |
| 5 | TESK2 | 3.12155161 |
| 6 | BUB1 | 3.03833844 |
| 7 | SIK1 | 2.80914151 |
| 8 | STK16 | 2.67556465 |
| 9 | PIM2 | 2.58284479 |
| 10 | VRK2 | 2.56489184 |
| 11 | MYLK | 2.49401187 |
| 12 | MAP4K1 | 2.16776837 |
| 13 | BLK | 2.13355487 |
| 14 | CDK19 | 2.06487326 |
| 15 | MUSK | 1.82270978 |
| 16 | MAP3K3 | 1.78390273 |
| 17 | PKN2 | 1.72560558 |
| 18 | MAP3K11 | 1.69454740 |
| 19 | PBK | 1.68262616 |
| 20 | RPS6KB2 | 1.66340897 |
| 21 | SMG1 | 1.62227828 |
| 22 | KDR | 1.59949671 |
| 23 | VRK1 | 1.56492440 |
| 24 | TNK2 | 1.53917898 |
| 25 | EIF2AK3 | 1.53633243 |
| 26 | MAP2K2 | 1.49115946 |
| 27 | WEE1 | 1.46508310 |
| 28 | NME1 | 1.45265422 |
| 29 | LRRK2 | 1.43822040 |
| 30 | IRAK3 | 1.43285941 |
| 31 | TAOK1 | 1.43071475 |
| 32 | MST4 | 1.37532532 |
| 33 | IRAK4 | 1.36685310 |
| 34 | ERN1 | 1.36070147 |
| 35 | DAPK3 | 1.31781850 |
| 36 | MST1R | 1.30951925 |
| 37 | MAP3K12 | 1.28667712 |
| 38 | ILK | 1.26243796 |
| 39 | TGFBR2 | 1.15401390 |
| 40 | BCKDK | 1.15163570 |
| 41 | STK39 | 1.15050521 |
| 42 | TEC | 1.14539682 |
| 43 | CLK1 | 1.14020362 |
| 44 | TAOK2 | 1.10606828 |
| 45 | SRPK1 | 1.09454465 |
| 46 | TESK1 | 1.06892934 |
| 47 | DYRK3 | 1.05443132 |
| 48 | PIM1 | 1.03565889 |
| 49 | FER | 1.00657426 |
| 50 | STK10 | 0.97279183 |
| 51 | MAP3K10 | 0.95205909 |
| 52 | RPS6KA4 | 0.94182635 |
| 53 | GRK5 | 0.93520363 |
| 54 | PTK2 | 0.92395683 |
| 55 | TBK1 | 0.91776373 |
| 56 | LIMK1 | 0.91404220 |
| 57 | BTK | 0.91387459 |
| 58 | ABL2 | 0.90927144 |
| 59 | IKBKB | 0.90611736 |
| 60 | MKNK2 | 0.90437691 |
| 61 | ZAP70 | 0.90330099 |
| 62 | AURKB | 0.89841797 |
| 63 | MAP3K8 | 0.89833236 |
| 64 | CDK7 | 0.87657320 |
| 65 | OXSR1 | 0.87495001 |
| 66 | PTK6 | 0.87302141 |
| 67 | STK4 | 0.87260415 |
| 68 | BMX | 0.86723771 |
| 69 | RPS6KA5 | 0.86539202 |
| 70 | BRAF | 0.85546849 |
| 71 | MAPK15 | 0.85397569 |
| 72 | PDPK1 | 0.85141585 |
| 73 | PAK1 | 0.84637782 |
| 74 | GRK7 | 0.84094761 |
| 75 | KIT | 0.83736766 |
| 76 | PRKD2 | 0.82033345 |
| 77 | IKBKE | 0.81684436 |
| 78 | SCYL2 | 0.79880579 |
| 79 | CHUK | 0.79178942 |
| 80 | AURKA | 0.77827800 |
| 81 | PAK4 | 0.77702892 |
| 82 | MKNK1 | 0.77236432 |
| 83 | EPHB1 | 0.76412481 |
| 84 | BRSK2 | 0.75091583 |
| 85 | EPHB2 | 0.74947607 |
| 86 | MAP2K1 | 0.74062747 |
| 87 | RIPK4 | 0.73905609 |
| 88 | MAP2K3 | 0.73481114 |
| 89 | EPHA2 | 0.73010859 |
| 90 | HIPK2 | 0.71650985 |
| 91 | GRK6 | 0.70856665 |
| 92 | TXK | 0.69945879 |
| 93 | PRKG2 | 0.68238670 |
| 94 | PIK3CA | 0.67720248 |
| 95 | MAPKAPK3 | 0.66998153 |
| 96 | DDR2 | 0.66733103 |
| 97 | PRKD1 | 0.63840574 |
| 98 | NEK2 | 0.63439016 |
| 99 | MOS | 0.62043679 |
| 100 | EEF2K | 0.61016018 |
| 101 | IRAK2 | 0.60669940 |
| 102 | CDK8 | 0.60322987 |
| 103 | LMTK2 | 0.59955759 |
| 104 | PLK1 | 0.58992838 |
| 105 | CDC7 | 0.57499246 |
| 106 | FLT3 | 0.56343730 |
| 107 | RPS6KA2 | 0.56326305 |
| 108 | CAMK2G | 0.56303620 |
| 109 | MAP3K1 | 0.56222219 |
| 110 | MET | 0.55475638 |
| 111 | TAOK3 | 0.55172985 |
| 112 | LYN | 0.54226267 |
| 113 | TYK2 | 0.53145550 |
| 114 | MAPKAPK5 | 0.52480444 |
| 115 | CSF1R | 0.52281698 |
| 116 | WNK4 | 0.50552562 |
| 117 | PIK3CG | 0.48809964 |
| 118 | RPS6KC1 | 0.48621410 |
| 119 | RPS6KL1 | 0.48621410 |
| 120 | PLK4 | 0.47851144 |
| 121 | TTK | 0.47743021 |
| 122 | MAPK12 | 0.47325212 |
| 123 | NLK | 0.47160339 |
| 124 | SYK | 0.45925918 |
| 125 | LCK | 0.45756911 |
| 126 | TNIK | 0.45520969 |
| 127 | PDK1 | 0.44840730 |
| 128 | DYRK1B | 0.44681580 |
| 129 | PRKD3 | 0.44427382 |
| 130 | PRKCI | 0.43582962 |
| 131 | CDK9 | 0.43098617 |
| 132 | CSNK2A1 | 0.42392913 |
| 133 | RIPK1 | 0.42014810 |
| 134 | MAP2K6 | 0.41661723 |
| 135 | ROCK2 | 0.41238629 |
| 136 | CSNK2A2 | 0.40343743 |
| 137 | CDC42BPA | 0.39613664 |
| 138 | BRSK1 | 0.39488509 |
| 139 | AKT2 | 0.38560828 |
| 140 | MAPKAPK2 | 0.37298687 |
| 141 | CSK | 0.36461997 |
| 142 | ADRBK1 | 0.35065751 |
| 143 | IRAK1 | 0.35022288 |
| 144 | MARK3 | 0.34419396 |
| 145 | CDK4 | 0.34329219 |
| 146 | RPS6KA6 | 0.33501971 |
| 147 | MAPK11 | 0.32947601 |
| 148 | PRKCD | 0.32325503 |
| 149 | DAPK1 | 0.31514824 |
| 150 | ARAF | 0.31160115 |
| 151 | MAPK7 | 0.29482528 |
| 152 | PRKAA2 | 0.28342588 |
| 153 | MTOR | 0.27341492 |
| 154 | GSK3A | 0.26272483 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 6.69736772 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.40887537 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.01924481 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 2.96775358 |
| 5 | Sulfur relay system_Homo sapiens_hsa04122 | 2.76021072 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.70039756 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.63455566 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 2.61303062 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.44817391 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.21427624 |
| 11 | Lysosome_Homo sapiens_hsa04142 | 2.17975376 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 2.17104206 |
| 13 | Spliceosome_Homo sapiens_hsa03040 | 2.13832707 |
| 14 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.11650914 |
| 15 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.08601780 |
| 16 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.07897372 |
| 17 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.98682634 |
| 18 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.89460970 |
| 19 | Base excision repair_Homo sapiens_hsa03410 | 1.87757993 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87152730 |
| 21 | Alzheimers disease_Homo sapiens_hsa05010 | 1.86321821 |
| 22 | Huntingtons disease_Homo sapiens_hsa05016 | 1.85710099 |
| 23 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.80861609 |
| 24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.79646307 |
| 25 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.79186352 |
| 26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.70181153 |
| 27 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.70057026 |
| 28 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.67806006 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.56176239 |
| 30 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.47496750 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.41553525 |
| 32 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.38645100 |
| 33 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.37936054 |
| 34 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.34442688 |
| 35 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.31740759 |
| 36 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.26208188 |
| 37 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.24593281 |
| 38 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.23829378 |
| 39 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.21633436 |
| 40 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.20689578 |
| 41 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.18257336 |
| 42 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.14670017 |
| 43 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.13121928 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 1.08477486 |
| 45 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.06360348 |
| 46 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.05700521 |
| 47 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.97273669 |
| 48 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.94648915 |
| 49 | Purine metabolism_Homo sapiens_hsa00230 | 0.91465935 |
| 50 | Mineral absorption_Homo sapiens_hsa04978 | 0.91221902 |
| 51 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.91059429 |
| 52 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.90668046 |
| 53 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.89937525 |
| 54 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.89732558 |
| 55 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.89617924 |
| 56 | RNA transport_Homo sapiens_hsa03013 | 0.88945400 |
| 57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.88474532 |
| 58 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.88409646 |
| 59 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.87440958 |
| 60 | Cell cycle_Homo sapiens_hsa04110 | 0.85514416 |
| 61 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.79846189 |
| 62 | Basal transcription factors_Homo sapiens_hsa03022 | 0.78271361 |
| 63 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.76926543 |
| 64 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.75950137 |
| 65 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.75464273 |
| 66 | RNA degradation_Homo sapiens_hsa03018 | 0.75291462 |
| 67 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.73755760 |
| 68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73405917 |
| 69 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.72970223 |
| 70 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.72451138 |
| 71 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.71916917 |
| 72 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.70960121 |
| 73 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.69059115 |
| 74 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.69003193 |
| 75 | Endocytosis_Homo sapiens_hsa04144 | 0.68213409 |
| 76 | Hepatitis C_Homo sapiens_hsa05160 | 0.66471357 |
| 77 | Phagosome_Homo sapiens_hsa04145 | 0.66325417 |
| 78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.66215504 |
| 79 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.65123618 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.64343592 |
| 81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.64002414 |
| 82 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.62484517 |
| 83 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62272505 |
| 84 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.62164708 |
| 85 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.61905622 |
| 86 | Bladder cancer_Homo sapiens_hsa05219 | 0.60844239 |
| 87 | Platelet activation_Homo sapiens_hsa04611 | 0.60388105 |
| 88 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.57373606 |
| 89 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.56043388 |
| 90 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55321983 |
| 91 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.55159413 |
| 92 | Shigellosis_Homo sapiens_hsa05131 | 0.54308470 |
| 93 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.54095831 |
| 94 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.54012542 |
| 95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53784718 |
| 96 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53143695 |
| 97 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.53105648 |
| 98 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.52461304 |
| 99 | Malaria_Homo sapiens_hsa05144 | 0.52287818 |
| 100 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.51875948 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51199575 |
| 102 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.50541453 |
| 103 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.50458886 |
| 104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.50315446 |
| 105 | Leishmaniasis_Homo sapiens_hsa05140 | 0.49327804 |
| 106 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.49294856 |
| 107 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.49079962 |
| 108 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.48700442 |
| 109 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.48593260 |
| 110 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.47326610 |
| 111 | Apoptosis_Homo sapiens_hsa04210 | 0.47326476 |
| 112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46667359 |
| 113 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45702051 |
| 114 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.44600583 |
| 115 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43299124 |
| 116 | Histidine metabolism_Homo sapiens_hsa00340 | 0.40819837 |
| 117 | Asthma_Homo sapiens_hsa05310 | 0.40393919 |
| 118 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.37151494 |
| 119 | Amoebiasis_Homo sapiens_hsa05146 | 0.36831090 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36015994 |
| 121 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.35892126 |
| 122 | Measles_Homo sapiens_hsa05162 | 0.35661960 |
| 123 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.34616083 |
| 124 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.34546372 |
| 125 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34464115 |
| 126 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34359717 |
| 127 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.34347104 |
| 128 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.33460050 |
| 129 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.33236286 |
| 130 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.31300306 |
| 131 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.30825027 |
| 132 | Thyroid cancer_Homo sapiens_hsa05216 | 0.30161616 |
| 133 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.29837415 |
| 134 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.29750986 |
| 135 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.29408569 |
| 136 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.28734755 |
| 137 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.28581728 |
| 138 | Pertussis_Homo sapiens_hsa05133 | 0.28054454 |
| 139 | Allograft rejection_Homo sapiens_hsa05330 | 0.27928159 |
| 140 | Salmonella infection_Homo sapiens_hsa05132 | 0.27835915 |
| 141 | Carbon metabolism_Homo sapiens_hsa01200 | 0.27497170 |
| 142 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.27293039 |
| 143 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.26291426 |
| 144 | Peroxisome_Homo sapiens_hsa04146 | 0.26276956 |
| 145 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.26174768 |
| 146 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.25159082 |

